Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.544NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.448NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.425NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.354NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.503NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.623NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.588NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.64.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KZ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.63.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JE.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.83NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.8.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LA.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.25.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.16.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.57.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.44.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDD.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used